Lataa...
Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1
E74-like ETS transcription factor 5 (ELF5) is involved in a wide spectrum of biological processes, e.g., mammogenesis and tumor progression. We have identified a list of p300-interacting proteins in human breast cancer cells. Among these, ELF5 was found to interact with p300 via acetylation, and the...
Tallennettuna:
| Julkaisussa: | NPJ Precis Oncol |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group UK
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7979705/ https://ncbi.nlm.nih.gov/pubmed/33742100 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41698-021-00158-3 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|